Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function

Table 1 Characteristics of the examined number of patients in disease-stratified groups.

	No. of subjects	Age (yr)	Female/Male	Smokers/non-smokers
Sarcoidosis	83	40 ± 12	35/48	20/63
IPF	31	61 ± 12	14/17	9/22
EAA	29	47 ± 16	13/16	8/21
CVD	16	55 ± 11	7/9	4/12
SCL	13	51 ± 12	11/2	1/12
WG	14	49 ± 18	12/2	3/11
PLH	12	37 ± 13	4/8	12/0
Silicosis	12	43 ± 9	1/11	8/4
DIPF	10	63 ± 11	3/7	1/9
COP	5	58 ± 8	3/2	1/4
Healthy volunteers	36	39 ± 11	22/14	4/32

IPF - idiopathic pulmonary fibrosis, EAA - extrinsic allergic alveolitis, CVD - collagen vascular diseases, SCL - scleroderma, WG - Wegener's granulomatosis, PLH - pulmonary Langerhans cells histiocytosis, DIPF - drug-induced pulmonary fibrosis, COP - cryptogenic organizing pneumonia.

ISSN: 2047-783X